
Minister of Social Affairs Jakob Forssmed announces that the availability of estrogen drugs is increasing following efforts by the authorities.
AI-generated summary
The shortage of estrogen drugs has been a recurring problem in Sweden for a long time, partly due to a global demand that has exceeded manufacturing capacity.
The medicine contains the female sex hormone estrogen and is mainly used when hormone production decreases during and after menopause. The lack of the medicine has been recurring and affected thousands of women in Sweden.
- It is not the women who should have to hunt for these medicines, but now we have rearranged the work of the authorities so that they become much more active in getting these medicines into Sweden, says Jakob Forssmed.
On Wednesday, the Minister of Social Affairs, together with the Medical Products Agency and the Dental and Pharmaceutical Benefits Agency, presented the results of the authorities' government mission to strengthen access to estrogen drugs.
According to the Swedish Medicines Agency, the number of sold packages of the medicine that is taken through the skin has increased significantly compared to September last year, and the authority assesses that the efforts have contributed to the development.
There has been a shortage for a long time and is partly related to the fact that global demand has increased faster than manufacturers have been able to meet.
Forssmed cannot give an indication of when the situation may be completely resolved.
- It is difficult to say an exact date. What we can state today is that we have a very gratifying trend break in this regard. We see that the availability of all forms of estrogen drugs that are taken through the skin (patch, gel or spray) is increasing.
According to Forssmed, the fact that Sweden is governed by a transitional government does not mean that the work is being slowed down. The authorities have already changed their way of working after the assignments last spring.

Several organizations discourage transgender people from seeking care at the gender identity clinic in Gothenburg. An audit shows that the reception refuses referrals more often than others, which has attracted strong criticism and led to protests outside the premises.

Breast cancer is the most common form of cancer among Swedish women. Despite debate about the screening program's use of resources, the National Board of Health and Welfare and the Karolinska Institute show that early detection via mammography reduces mortality by up to 20 percent.
Charlize, who openly shared her battle against the aggressive blood cancer AML on social media, has died. After undergoing a stem cell transplant and chemotherapy, she was told in October that no further treatment was available.

Two people who traveled through Uganda's international airport have been confirmed with Ebola. Authorities are now investigating whether an interaction at the airport is behind the spread of the infection that has reached Nigeria and Kenya, which is creating concerns about further spread.
The Inspectorate for Care and Care (IVO) has been commissioned by the government to review the specialized eating disorder care in Sweden. The organization Frisk & Fri welcomes the decision and highlights problems with long queues and regional differences.
When a 12-year-old girl in the Stockholm area suffered from an eating disorder, the family faced long waiting times and a heavy responsibility for treatment. Today, the daughter is healthy and mother Nina emphasizes the importance of openness and early support.